Breast Intra-Ductal Injection of Orexin-A receptor antagonist (SB-334867-A) Decreases Gene Expression of Mammary Lipogenic Enzymes and Insulin Serum Levels in the Lactating rats.
- Published in:
- Novelty in Biomedicine, 2022, v. 10, n. 3, p. 152
- By:
- Publication type:
- Article